Can Fasting Boost Brain Health? Neurologist Explains Its Role In Memory, Neuroprotection And Cognitive Function

Last Updated:February 25, 2026, 13:41 IST

How intermittent fasting and time-restricted eating may support brain health, improve memory, and reduce neurodegeneration risk.

Current evidence supports the hypothesis that structured fasting regimens may enhance neuroplasticity and reduce risk factors associated with neurodegeneration

Growing evidence from preclinical and human studies suggests that fasting particularly intermittent fasting (IF) and time-restricted eating may exert neuroprotective effects through metabolic and molecular adaptations.

One primary mechanism involves metabolic switching, in which glycogen depletion shifts energy utilisation from glucose to ketone bodies. Ketones such as beta-hydroxybutyrate not only provide an efficient source of fuel for neurons but also function as signalling molecules that upregulate brain-derived neurotrophic factor (BDNF) (Mattson et al., 2018, NEJM). BDNF plays a central role in synaptic plasticity, learning, and memory consolidation.

Dr. Nilesh Chaudhary, Consultant Neurologist, Dr L. H. Hiranandani Hospital, Powai, shares his insights:

Animal studies demonstrate that intermittent fasting enhances synaptic resilience, reduces oxidative stress, and stimulates autophagy, a cellular repair pathway that clears misfolded proteins implicated in Alzheimer’s and Parkinson’s diseases (Longo & Mattson, 2014, Cell Metabolism). Rodent models have also shown improved hippocampal-dependent memory and reduced beta-amyloid accumulation under fasting protocols.

Human evidence, while more limited, is emerging. Randomised trials of time-restricted feeding have shown improvements in insulin sensitivity, reduced systemic inflammation, and enhanced metabolic flexibility (Sutton et al., 2018, Cell Metabolism). Given the strong association between metabolic dysfunction and cognitive decline, these findings suggest an indirect neuroprotective pathway.

Observational data also indicate that caloric restriction may slow age-related cognitive decline, although large-scale longitudinal trials are still ongoing.

Importantly, fasting is not appropriate for everyone. “Individuals with diabetes, eating disorders, frailty, or those taking glucose-lowering medications face an increased risk of hypoglycaemia and adverse outcomes,” cautions Dr Chaudhary. “Clinical supervision is recommended for at-risk populations.”

Current evidence supports the hypothesis that structured fasting regimens may enhance neuroplasticity and reduce risk factors associated with neurodegeneration. However, definitive conclusions regarding long-term cognitive outcomes in humans require further randomised controlled trials.